Good morning :)
Place Order
Add to Watchlist

Suven Life Sciences Ltd

SUVEN

Suven Life Sciences Ltd

SUVEN
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,835 cr, stock is ranked 1,000
High RiskStock is 4.37x as volatile as Nifty
84.050.12% (-0.10)
84.050.12% (-0.10)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,835 cr, stock is ranked 1,000
High RiskStock is 4.37x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,835 cr, stock is ranked 1,000
High RiskStock is 4.37x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
-15.894.89
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
44.315.090.71%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Suven Life Sciences Limited is a bio-pharmaceutical company, engaged in the business of manufacture and sale of bulk drugs and intermediaries.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of -46.66%, vs industry avg of 8.45%

Decreasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.32% to 0.01%

Loading...

Financial YearFY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023TTM
Total Revenue529.44518.81564.62648.53312.9228.4521.2317.1627.9938.52
Raw Materialssubtract177.25178.45154.81176.1679.620.000.000.000.00147.10
Power & Fuel Costsubtract28.0429.3231.5033.5619.371.630.000.000.00
Employee Costsubtract36.5140.9452.1761.2736.4917.4118.5321.0218.62
Selling & Administrative Expensessubtract74.42113.67124.44117.18136.02107.8873.85109.14118.30
Operating & Other expensessubtract45.1835.4851.5438.8928.563.211.043.932.26
Depreciation/Amortizationsubtract11.7817.5021.4121.3110.794.174.354.396.546.73
Interest & Other Itemssubtract4.715.885.684.631.910.550.940.670.540.20
Taxes & Other Itemssubtract42.8125.7335.8871.8424.06-12.18-5.320.000.00
EPS0.430.260.320.45-0.09-0.65-5.22-8.25-6.29-5.30
DPS0.030.090.050.070.070.000.000.000.000.00
Payout ratio0.060.350.150.150.000.000.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2018

Annual Report Unavailable

Investor Presentation

May 15PDF
Jan 30PDF
Nov 11PDF
FY 2019

Annual report

PDF

Investor Presentation

May 25PDF
Feb 5PDF
Feb 5PDF
+2 more
FY 2020

Annual report

PDF

Investor Presentation

Nov 14PDF
Aug 14PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Suven Life Sciences Ltd-15.524.89
Sun Pharmaceutical Industries Ltd34.714.960.94%
Cipla Ltd34.934.130.70%
Dr Reddy's Laboratories Ltd21.384.140.69%

Price Comparison

Compare SUVEN with any stock or ETF
Compare SUVEN with any stock or ETF
SUVEN
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Increased Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has increased by 1.07%

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding69.57%0.01%0.00%0.50%29.93%

Dec 2022

Mar 2023

Jun 2023

Sep 2023

Shareholding History

SepNovDec '22MarJunSep0.48%0.49%0.45%0.51%0.47%0.50%

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateFeb 17, 2021

Interim
Interim | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Feb 17, 2021

Cash Dividend

Ex DateEx DateFeb 14, 2019

Interim
Interim | Div/Share: ₹1.50

Dividend/Share

1.50

Ex DateEx Date

Feb 14, 2019

Cash Dividend

Ex DateEx DateFeb 6, 2018

Interim
Interim | Div/Share: ₹1.50

Dividend/Share

1.50

Ex DateEx Date

Feb 6, 2018

Cash Dividend

Ex DateEx DateFeb 8, 2017

Interim
Interim | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Feb 8, 2017

Cash Dividend

Ex DateEx DateMar 14, 2016

Interim
Interim | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Mar 14, 2016